These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7564365)

  • 21. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA; Reid JL; Vincent J
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive effect of naftopidil (KT-611), a novel alpha 1-adrenoceptor antagonist, in freely moving experimental hypertensive rats and dogs].
    Kawasaki H; Nakamura S; Takasaki K; Iwamoto T; Ohjimi H; Kushiku K; Furukawa T
    Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):129-39. PubMed ID: 1980256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Yu SM; Hsu SY; Ko FN; Chen CC; Huang YL; Huang TF; Teng CM
    Br J Pharmacol; 1992 Aug; 106(4):797-801. PubMed ID: 1356567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the interactions between the angiotensin converting enzyme inhibitor enalaprilat and calcium antagonists in rats.
    Marwood JF
    J Hypertens; 1996 Jan; 14(1):123-9. PubMed ID: 12013484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of monatepil, a new calcium antagonist, in the treatment of essential hypertension.
    Ishii M; Iimura O; Yoshinaga K; Abe K; Inagaki Y; Yagi S; Kuramoto K; Kajiwara N; Saruta T; Kuramochi M
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):141S-145S. PubMed ID: 7826564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK; Kellar KJ; Gillis RA
    J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium entry blocking, beta 1-adrenoceptor blocking and hypotensive effects of YM-16151-4.
    Shibasaki K; Uchida W; Matsuda Y; Asano M
    Arch Int Pharmacodyn Ther; 1991; 313():140-50. PubMed ID: 1687772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
    Tomlinson B; Renondin JC; Graham BR; Prichard BN
    Eur J Clin Pharmacol; 1991; 41(1):1-3. PubMed ID: 1685992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W; Nakagawa Y; Mitomi A; Imai S
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.
    Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
    Nakahara H; Nakazawa M; Takeda K; Imai S
    Jpn J Pharmacol; 1985 Dec; 39(4):487-92. PubMed ID: 2419613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotensive effect in dogs and rats of intravenous injections of the alpha 1-adrenoreceptor antagonist benoxathian.
    Massi M; Venturi F; Brasili L; Melchiorre C
    Pharmacol Res Commun; 1986 Sep; 18(9):813-29. PubMed ID: 2879293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.
    Ruffolo RR; Morgan EL; Messick K
    J Pharmacol Exp Ther; 1984 Sep; 230(3):587-94. PubMed ID: 6088757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats.
    Wang EQ; Fung HL
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):341-6. PubMed ID: 15076216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.